Preferred Label : Eicosapentaenoate Docosahexaenoate/Fatty acids.C14-C24:SFr:Pt:Ser/Plas:Qn:;
LOINC status : ACTIVE;
LOINC display name : EPA DHA/Fatty acids.C14-C24 [Molar fraction];
LOINC long common name : Omega-3 (EPA DHA) index in Serum or Plasma;
LOINC short name : Omega-3 index SFr SerPl;
LOINC description : The omega-3 index, defined as eicosapentaenoate (EPA) docosahexaenoate (DHA)/Fatty
acids.C14-C24, is a clinically useful measurement for evaluating blood levels of EPA
and DHA. There are many health benefits from maintaining a good level of omega-3 fatty
acids including reduced inflammation, risk of heart disease, cancer, arthritis, and
many more. Deficiency in omega-3 fatty acids can result in fatigue, poor memory, dry
skin, heart problems, mood swings, and poor circulation.[https://www.umm.edu/health/medical/altmed/supplement/omega3-fatty-acids]
There have been a number of clinical trials to determine the effect of omega-3 supplementation
based on a 1g/day dose of EPA, which successfully increased the total omega-3 level
to 5% for 84% of the study participants. The remaining 16% had levels below 5%, which
is the threshold at which significant reduction in sudden coronary death reduction
is evident. The variability in the blood levels of omega-3 in patients who received
the same supplemental dose of omega-3 has been attributed to genetic differences in
fatty acid metabolism, body weight, baseline omega-3 level, age, gender, and physical
activity.[PMID: 25285179];
Origin ID : 88998-0;
UMLS CUI : C4696279;
Has component
- Has property
- Has system
- Has time aspect
- Part of panel
- Semantic type(s)
